Market Cap (In CHF)
4.77 Billion
Revenue (In CHF)
577.31 Million
Net Income (In CHF)
111.85 Million
Avg. Volume
59.48 Thousand
- Currency
- CHF
- Country
- Basic Materials
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 53.95-91.65
- PE
- -
- EPS
- -
- Beta Value
- 0.722
- ISIN
- CH1176493729
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Mr. Thomas Meier
- Employee Count
- -
- Website
- https://www.bachem.com
- Ipo Date
- 1998-07-17
- Details
- Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
More Stocks
-
NIBL
-
TIGO
-
OROXFOrosur Mining Inc.
OROXF
-
BNRUDYBNR Udyog Limited
BNRUDY
-
002603
-
300417Nanhua Instruments Co., Ltd.
300417
-
RIVN
-
DELTA